Nanomedicine and Immunotherapy for Cancers

A. A. Navas, N. Doreswamy and P. J. Joseph Francis
Additional contact information
A. A. Navas: National University of Science and Technology, Sultanate of Oman
N. Doreswamy: National Coalition of Independent Scholars, Australia
P. J. Joseph Francis: National University of Science and Technology, Sultanate of Oman

European Journal of Medical and Health Sciences, 2020, vol. 2, issue 5

Abstract: Nanomedicine contributes to cancer therapeutics in several ways, harnessing some of the remarkable properties of nanomaterials to target tumor cells with increasing specificity. Nano-scale therapeutic strategies enable the simultaneous transport of hydrophilic and hydrophobic drugs across physical and physiological barriers like the blood-brain barrier. Alternative routes of drug administration, such as the intranasal route, have become viable, with more promising therapies for highly lethal tumors like glioblastomas. Cancer nanomedicine allows increased solubility and bioavailability of anti-cancer drugs, reducing their toxicity. Multi-drug delivery systems such as dendrimers, noble metal nanoparticle drug delivery systems, nanoparticle-based theranostics, and nano-biomarkers may well bring about a sea change in cancer therapeutics. This review presents an overview of the scope of cancer nanomedicine, including immunotherapy for cancer.

Keywords: Nanomedicine; Immunotherapy; Theranostics; Tumor heterogeneity; Cytokine Release Syndrome; Cancer Nanomedicine (search for similar items in EconPapers)
Date: 2020
References: Add references at CitEc
Citations:

Downloads: (external link)
https://eu-opensci.org/index.php/ejmed/article/view/40482 Abstract page (text/html)
https://eu-opensci.org/index.php/ejmed/article/download/40482/9037 Full text (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:epw:ejmed0:v:2:y:2020:i:5:id:40482

DOI: 10.24018/ejmed.2020.2.5.482

Access Statistics for this article

More articles in European Journal of Medical and Health Sciences from European Open Science
Bibliographic data for series maintained by Support ().